Hyperacute renal allograft rejection in the primate. Therapeutic limitations of antiplatelet agents alone and combined with heparin.

@article{Colman1976HyperacuteRA,
  title={Hyperacute renal allograft rejection in the primate. Therapeutic limitations of antiplatelet agents alone and combined with heparin.},
  author={Robert W. Colman and Mutaz B. Habal and Norman Kenneth Hollenberg and Alan G. Birtch and G{\"u}nther Busch},
  journal={The American journal of pathology},
  year={1976},
  volume={82 1},
  pages={25-42}
}
Two antiplatelet drugs, pyridinolcarbamate and Sudoxicam, were tested separately and in combination with heparin for their ability to modify experimental hyperacute renal allograft rejection in primates. Pyridinolcarbamate delayed and amerliorated tissue injury and obstructive thrombosis but only minimally prolonged renal blood flow over that seen in… CONTINUE READING